Publication | Closed Access

Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase

Medicinal ChemistryBiochemistryFunctional SelectivityMedicineActive InhibitorsNatural SciencesMechanism Of ActionPharmacological AgentPharmacotherapyPharmacologyNeutral 5-Substituted 4-IndazolylaminoquinazolinesInhibitory ActivityDrug DiscoveryDrug Resistance